Xcelerate Inc (XCRT)
0.028
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 3.208M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -47.17% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 98.54% |
Profile
| Xcelerate Inc has assembled an internationally recognized team of translational clinicians, engineers and business leaders to identify, acquire, and develop engineering advancements, intellectual property and operating business in, or with applications in medical technology and clinical care. It intends to acquire innovation at the engineering/patent level, marry it with appropriate early-stage operational med-tech companies and apply it in a controlled clinical care setting which fosters engineering/clinical/business advancements under one umbrella. |
| URL | https://www.xcelerate.global |
| Investor Relations URL | N/A |
| HQ State/Province | South Carolina |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Equity Style | Small Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Xcelerate Inc has assembled an internationally recognized team of translational clinicians, engineers and business leaders to identify, acquire, and develop engineering advancements, intellectual property and operating business in, or with applications in medical technology and clinical care. It intends to acquire innovation at the engineering/patent level, marry it with appropriate early-stage operational med-tech companies and apply it in a controlled clinical care setting which fosters engineering/clinical/business advancements under one umbrella. |
| URL | https://www.xcelerate.global |
| Investor Relations URL | N/A |
| HQ State/Province | South Carolina |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Equity Style | Small Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |